Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea B Apolo

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
The Urologic Clinics of North America|April 18, 2015
Trimodality therapy in bladder cancer: who, what, and when?Christopher Premo, Andrea B Apolo, Piyush K Agarwal, et al.
Clinical Genitourinary Cancer|January 13, 2018
Anti-Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future DevelopmentThomas Powles, Andrea Necchi, Galit Rosen, et al.
Frontiers in Cellular Neuroscience|September 29, 2017
Magnetic Nanoparticle Mediated Steroid Delivery Mitigates Cisplatin Induced Hearing LossBharath Ramaswamy, Soumen Roy, Andrea B Apolo, et al.
European Journal of Radiology|July 8, 2015
Viable tumor volume: Volume of interest within segmented metastatic lesions, a pilot study of proposed computed tomography response criteria for urothelial cancerLes Roger Folio, Evrim B Turkbey, Seth M Steinberg, et al.
AJR. American Journal of Roentgenology|January 24, 2017
Radiology Reports With Hyperlinks Improve Target Lesion Selection and Measurement Concordance in Cancer TrialsLaura B Machado, Andrea B Apolo, Seth M Steinberg, et al.
Cancers|December 24, 2014
Characterization of HGF/Met Signaling in Cell Lines Derived From Urothelial Carcinoma of the BladderYoung H Lee, Andrea B Apolo, Piyush K Agarwal, et al.
Cancer Treatment Reviews|January 16, 2022
Management of adverse events associated with cabozantinib plus nivolumab in renal cell carcinoma: A reviewBradley McGregor, Amir Mortazavi, Lisa Cordes, et al.
Urologic Oncology|December 11, 2012
Practical use of perioperative chemotherapy for muscle-invasive bladder cancer: summary of session at the Society of Urologic Oncology annual meetingAndrea B Apolo, Herbert Barton Grossman, Dean Bajorin, et al.
AJR. American Journal of Roentgenology|August 27, 2013
Consistency and efficiency of CT analysis of metastatic disease: semiautomated lesion management application within a PACSLes R Folio, Aline Sandouk, Jiaxin Huang, et al.
Urologic Oncology|November 10, 2021
Systemic therapy issues: Immunotherapy in nonmetastatic urothelial cancerRosa Nadal, Andrea B Apolo, Daniel M Girardi, et al.
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
The Urologic Clinics of North America|April 18, 2015
Trimodality therapy in bladder cancer: who, what, and when?Christopher Premo, Andrea B Apolo, Piyush K Agarwal, et al.
Clinical Genitourinary Cancer|January 13, 2018
Anti-Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future DevelopmentThomas Powles, Andrea Necchi, Galit Rosen, et al.
Frontiers in Cellular Neuroscience|September 29, 2017
Magnetic Nanoparticle Mediated Steroid Delivery Mitigates Cisplatin Induced Hearing LossBharath Ramaswamy, Soumen Roy, Andrea B Apolo, et al.
European Journal of Radiology|July 8, 2015
Viable tumor volume: Volume of interest within segmented metastatic lesions, a pilot study of proposed computed tomography response criteria for urothelial cancerLes Roger Folio, Evrim B Turkbey, Seth M Steinberg, et al.
AJR. American Journal of Roentgenology|January 24, 2017
Radiology Reports With Hyperlinks Improve Target Lesion Selection and Measurement Concordance in Cancer TrialsLaura B Machado, Andrea B Apolo, Seth M Steinberg, et al.
Cancers|December 24, 2014
Characterization of HGF/Met Signaling in Cell Lines Derived From Urothelial Carcinoma of the BladderYoung H Lee, Andrea B Apolo, Piyush K Agarwal, et al.
Cancer Treatment Reviews|January 16, 2022
Management of adverse events associated with cabozantinib plus nivolumab in renal cell carcinoma: A reviewBradley McGregor, Amir Mortazavi, Lisa Cordes, et al.
Urologic Oncology|December 11, 2012
Practical use of perioperative chemotherapy for muscle-invasive bladder cancer: summary of session at the Society of Urologic Oncology annual meetingAndrea B Apolo, Herbert Barton Grossman, Dean Bajorin, et al.
AJR. American Journal of Roentgenology|August 27, 2013
Consistency and efficiency of CT analysis of metastatic disease: semiautomated lesion management application within a PACSLes R Folio, Aline Sandouk, Jiaxin Huang, et al.
Urologic Oncology|November 10, 2021
Systemic therapy issues: Immunotherapy in nonmetastatic urothelial cancerRosa Nadal, Andrea B Apolo, Daniel M Girardi, et al.
Pageof 12